TIGAR是一种p53可诱导的糖解和亡调节剂
相关实验视频
Updated: Jun 23, 2026

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Karim Bensaad1, Atsushi Tsuruta, Mary A Selak
1The Beatson Institute for Cancer Research, Switchback Road, Glasgow G61 1BD, UK.
Cell
|July 15, 2006
概括
瘤抑制剂p53通过TIGAR基因调节细胞死亡. 提加减少活性氧物种 (ROS) 和糖解,保护细胞免受p53诱导的亡和基因组损伤.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞的新陈代谢
背景情况:
- 瘤抑制蛋白p53对于预防癌症至关重要.
- 通过细胞循环停止,细胞亡和维持基因组稳定性,p53的功能.
研究的目的:
- 确定新的p53诱导基因.
- 研究TIGAR (TP53诱导的葡萄糖分解和亡调节器) 在p53介导的细胞反应中的作用.
主要方法:
- 对p53诱导基因表达的分析.
- 测量果糖-2,6-双酸盐和细胞内活性氧物种 (ROS) 的水平.
- 评估细胞亡和对p53诱导死亡的敏感性.
主要成果:
- 确定了TIGAR作为一个p53诱导基因.
- TIGAR表达减少了果糖-2,6-双酸盐,抑制了葡萄糖分解并降低了细胞内ROS.
- TIGAR保护细胞免受ROS相关的亡;TIGAR knockdown使细胞敏感到p53诱导的死亡.
结论:
- TIGAR调节对p53的亡反应,促进细胞在压力下存活.
- 由TIGAR减少的细胞内ROS有助于p53在预防基因组损伤方面的作用.
相关概念视频
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

